- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/665 - Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
Patent holdings for IPC class A61K 31/665
Total number of patents in this class: 474
10-year publication summary
|
39
|
47
|
34
|
40
|
27
|
33
|
23
|
35
|
30
|
19
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Viking Therapeutics, Inc. | 65 |
22 |
| Gilead Sciences, Inc. | 2243 |
13 |
| Reponex Pharmaceuticals ApS | 19 |
12 |
| Metabasis Therapeutics, Inc. | 38 |
11 |
| Gannex Pharma Co., Ltd. | 31 |
9 |
| Helperby Therapeutics Limited | 61 |
8 |
| Immunogenesis, Inc. | 20 |
7 |
| Phost'in Therapeutics | 7 |
7 |
| Cellectar Biosciences, Inc. | 25 |
6 |
| Sansho Co. Ltd. | 17 |
6 |
| Allergan, Inc. | 2155 |
5 |
| Showa Denko K.K. | 2061 |
5 |
| Otsuka Chemical Co., Ltd. | 282 |
5 |
| Savara Inc. | 20 |
5 |
| Fleurir ABX LLC | 12 |
5 |
| Curology, Inc. | 65 |
5 |
| Metro International Biotech, LLC | 41 |
5 |
| Meitheal Pharmaceuticals, Inc. | 26 |
5 |
| AXCESO BIOPHARMA Co., Ltd. | 15 |
5 |
| Centre National de La Recherche Scientifique | 11092 |
4 |
| Other owners | 324 |